For SaaS and technology investors
Six independent reviewers read the deck, the metrics, and the data room separately: product, security and compliance, go-to-market, market, financials, and a Devil's Advocate. A Chair turns what they find into one recommendation with page-level citations.
The problem
ARR that includes one-time services, net revenue retention measured on a flattering cohort, CAC payback that leaves out sales salaries. The Go-to-Market reviewer asks how each number was built, and anything the materials don't support is labeled an assumption.
A pipeline full of enterprise logos means little if the company can't pass a security review. A dedicated reviewer looks at SOC 2 status, data handling, past incidents, and exposure under rules like HIPAA or GDPR.
The Product reviewer asks what's actually hard to copy: the architecture, the data, workflow lock-in, or none of them. The Market reviewer looks separately at switching costs and pricing power.
A first pass that separates evidence from pitch shows which deals deserve a partner meeting, and gives you focused questions for the next founder call.
Your committee
Every reviewer gets a narrow mandate. The Product reviewer sticks to the product and the technology. The Go-to-Market reviewer assumes the product works and asks whether the sales motion, pipeline, churn, and retention support the plan. The Market reviewer asks whether the market will sustain the thesis. The Financial reviewer covers valuation, burn, runway, unit economics, and dilution.
None of them sees another reviewer's report. The Devil's Advocate then makes the strongest evidence-based case against investing. The Chair doesn't average the scores: it shows where the reviewers disagree and why, and keeps cited facts separate from judgment.
You choose the committee per deal when you create it. Software deals get this six-member committee, and life sciences deals get a seven-member committee built for biotech.
Built for confidential materials
Your workspace is isolated from every other organization. Factual claims must cite the source material, and assumptions and judgments are labeled as such, so evidence and opinion stay separate.
Read about security and data handling →Software, infrastructure, developer tools, fintech, and other technology companies where product, go-to-market, and security posture drive the outcome. Health tech that is mostly software usually fits here. Drug and device companies fit the Life Sciences committee.
Every factual claim has to cite a document and page. If the deck says 140% net revenue retention and nothing else in the materials supports it, the report shows it as unsupported, and it usually turns into a diligence question.
You pick the model for each committee run from a curated list that includes GPT-5 and Claude. When you choose a hosted model, the deal materials are sent to that provider for analysis. The security page explains how that data is handled.
Free to start
Create a free workspace and run your first committee analysis in minutes. No credit card required.
Start free →Conviction is decision-support software, not investment, medical, or legal advice.